Newsbenzinga
Bristol-Myers Squibb Says AI Is Already Speeding Up Drug Research — And It's Measuring The Impact
· Published
Article summary
Bristol-Myers beats Q3 2026 estimates with $13.07B in revenue and raises full-year sales guidance driven by newer drug growth.
An excerpt from the original article.
Comments —
Loading comments…